DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Nitrazepam is an investigational drug.
There have been 4 clinical trials for Nitrazepam. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2015.
The most common disease conditions in clinical trials are Epilepsy, Anxiety Disorders, and Sleep Initiation and Maintenance Disorders. The leading clinical trial sponsors are National Institute for Health Research, United Kingdom, Birmingham Children's Hospital NHS Foundation Trust, and Matthew's Friends.
There is one US patent protecting this investigational drug and fifteen international patents.
Recent Clinical Trials for Nitrazepam
|Ketogenic Diet in Infants With Epilepsy (KIWE)||Alder Hey Children's NHS Foundation Trust||Phase 4|
|Ketogenic Diet in Infants With Epilepsy (KIWE)||Birmingham Children's Hospital NHS Foundation Trust||Phase 4|
|Ketogenic Diet in Infants With Epilepsy (KIWE)||Bristol Royal Hospital for Children||Phase 4|
Top disease conditions for Nitrazepam
Top clinical trial sponsors for Nitrazepam
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Nitrazepam||Start Trial||Heterocyclic compound||Takeda Pharmaceutical Company Limited (Osaka, JP)||Start Trial|
|Nitrazepam||Start Trial||Methyl diazepane orexin receptor antagonists||Merck Sharp & Dohme Corp. (Rahway, NJ)||Start Trial|
|Nitrazepam||Start Trial||Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof||The Regents of the University of California (Oakland, CA)||Start Trial|
|Nitrazepam||Start Trial||Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse||Acura Pharmaceuticals, Inc. (Palatine, IL)||Start Trial|
|Nitrazepam||Start Trial||Tamper-resistant pharmaceutical compositions of opioids and other drugs||COLLEGIUM PHARMACEUTICAL, INC. (Canton, MA)||Start Trial|
|Nitrazepam||Start Trial||Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Nitrazepam||European Patent Office||3192791||2034-09-11||Start Trial|
|Nitrazepam||World Intellectual Property Organization (WIPO)||2016039408||2034-09-11||Start Trial|
|Nitrazepam||World Intellectual Property Organization (WIPO)||2016085784||2034-11-26||Start Trial|
|Nitrazepam||European Patent Office||2981556||2033-04-02||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|